Nutrition Brands Limited 31/08/2022 iXBRL


0 31/08/2022 2022-08-31 false false false false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2021-09-01 Sage Accounts Production 21.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 9722148 2021-09-01 2022-08-31 9722148 2022-08-31 9722148 2020-09-01 2021-08-31 9722148 2021-08-31 9722148 2020-08-31 9722148 bus:RegisteredOffice 2021-09-01 2022-08-31 9722148 bus:LeadAgentIfApplicable 2021-09-01 2022-08-31 9722148 bus:Director1 2021-09-01 2022-08-31 9722148 bus:Director2 2021-09-01 2022-08-31 9722148 bus:Director3 2021-09-01 2022-08-31 9722148 bus:Director4 2021-09-01 2022-08-31 9722148 bus:CompanySecretary1 2021-09-01 2022-08-31 9722148 core:RetainedEarningsAccumulatedLosses 2020-09-01 2021-08-31 9722148 core:RetainedEarningsAccumulatedLosses 2021-09-01 2022-08-31 9722148 core:WithinOneYear 2022-08-31 9722148 core:WithinOneYear 2021-08-31 9722148 core:ShareCapital 2022-08-31 9722148 core:ShareCapital 2021-08-31 9722148 core:RetainedEarningsAccumulatedLosses 2022-08-31 9722148 core:RetainedEarningsAccumulatedLosses 2021-08-31 9722148 core:ShareCapital 2020-08-31 9722148 core:RetainedEarningsAccumulatedLosses 2020-08-31 9722148 bus:SmallEntities 2021-09-01 2022-08-31 9722148 bus:AuditExempt-NoAccountantsReport 2021-09-01 2022-08-31 9722148 bus:FullAccounts 2021-09-01 2022-08-31 9722148 bus:SmallCompaniesRegimeForAccounts 2021-09-01 2022-08-31 9722148 bus:PrivateLimitedCompanyLtd 2021-09-01 2022-08-31
Company registration number: 9722148
Nutrition Brands Limited
Unaudited filleted financial statements
31 August 2022
Nutrition Brands Limited
Contents
Directors and other information
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Nutrition Brands Limited
Directors and other information
Directors Mr Sanjiv Shah
Mr Jatish Malde
Mr Divyesh Malde
Mr Miraj Malde
Secretary Jatish Malde
Company number 9722148
Registered office The Pavilion
56 Rosslyn Crescent
Harrow
Middlesex
HA1 2SZ
Business address The Pavilion
56 Rosslyn Crescent
Harrow
Middlesex
HA1 2SZ
Accountants P R Shah & Co
10 Bouverie Gardens
Kenton
Harrow
Middlesex
HA3 0RQ
Bankers Nat West
Harrow Town Centre
315 Station Road
Harrow
Middlesex. HA1 2AD
Nutrition Brands Limited
Statement of financial position
31 August 2022
2022 2021
Note £ £ £ £
Current assets
Stocks 159,569 218,440
Debtors 4 46,989 99,783
Cash at bank and in hand 465,098 419,807
_______ _______
671,656 738,030
Creditors: amounts falling due
within one year 5 ( 110,250) ( 170,713)
_______ _______
Net current assets 561,406 567,317
_______ _______
Total assets less current liabilities 561,406 567,317
_______ _______
Net assets 561,406 567,317
_______ _______
Capital and reserves
Called up share capital 150,000 150,000
Profit and loss account 411,406 417,317
_______ _______
Shareholders funds 561,406 567,317
_______ _______
For the year ending 31 August 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 14 February 2023 , and are signed on behalf of the board by:
Mr Sanjiv Shah
Director
Company registration number: 9722148
Nutrition Brands Limited
Statement of changes in equity
Year ended 31 August 2022
Called up share capital Profit and loss account Total
£ £ £
At 1 September 2020 150,000 169,777 319,777
(Loss)/profit for the year 247,540 247,540
_______ _______ _______
Total comprehensive income for the year - 247,540 247,540
_______ _______ _______
At 31 August 2021 and 1 September 2021 150,000 417,317 567,317
(Loss)/profit for the year ( 5,911) ( 5,911)
_______ _______ _______
Total comprehensive income for the year - ( 5,911) ( 5,911)
_______ _______ _______
At 31 August 2022 150,000 411,406 561,406
_______ _______ _______
Nutrition Brands Limited
Notes to the financial statements
Year ended 31 August 2022
1. General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is Nutrition Brands Limited, The Pavilion, 56 Rosslyn Crescent, Harrow, Middlesex, HA1 2SZ.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Debtors
2022 2021
£ £
Trade debtors 42,228 95,947
Other debtors 4,761 3,836
_______ _______
46,989 99,783
_______ _______
5. Creditors: amounts falling due within one year
2022 2021
£ £
Trade creditors 48,350 50,817
Corporation tax - 58,096
Other creditors 61,900 61,800
_______ _______
110,250 170,713
_______ _______